If you choose the sublingual route, understand that you are using a less-studied formulation and monitor your results accordingly
Also, the mean A1c level at intensification with either an oral agent or insulin was 8.7, 9.1 and 9.7% for patients taking one, two or three oral agents [8]
Given the costs typically associated with injectable weight-management therapies and existing NHS prescribing frameworks, access if approved may initially be limited to specific patient groups meeting defined clinical criteria, as has been the case with other agents in this class
Some patients may notice increased awareness of breathing during physical activity as they become more active following weight loss
That, in a single column, is the tirzepatide vs semaglutide gap that kicked off the whole conversation
How could we offset the potential of lost volume in some categories if we are impacted